Design, Synthesis, and Evaluation of a Series of Novel Super Long-Acting DPP-4 Inhibitors for the Treatment of Type 2 Diabetes-Reference-Cited by-同舟云学术

Design, Synthesis, and Evaluation of a Series of Novel Super Long-Acting DPP-4 Inhibitors for the Treatment of Type 2 Diabetes

Published:2020-05-26 Issue:13 Volume:63 Page:7108-7126
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zhang Chen¹^ORCID,Ye Fei¹,Wang Jianmin¹,He Ping¹,Lei Ming¹,Huang Longbin¹,Huang Anbang¹,Tang Pingming¹,Lin Hongjun¹,Liao Yuting¹,Liang Yong¹,Ni Jia¹,Yan Pangke¹

Affiliation:

1. Haisco Pharmaceutical Group Company Ltd., 136 Baili Road, Wenjiang district, Chengdu 611130, China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00374

Reference50 articles.

1. Global estimates of diabetes prevalence for 2013 and projections for 2035

2. https://diabetesatlas.org/en/ (accessed Feb 28, 2020).

3. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors

4. Using Electronic Health Records to Improve Outpatient Diabetes Care

5. Management of type 2 diabetes: new and future developments in treatment

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the selective and nanomolar inhibitor of DPP-4 more potent than sitagliptin by structure-guided rational design;European Journal of Medicinal Chemistry;2024-12

2. Advances in small-molecule insulin secretagogues for diabetes treatment;Biomedicine & Pharmacotherapy;2024-09

3. Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM);European Journal of Medicinal Chemistry;2024-06

4. Concentration‐QTc Modeling of the DPP‐4 Inhibitor HSK7653 in a First‐in‐Human Study of Chinese Healthy Volunteers;Clinical Pharmacology in Drug Development;2024-05-17

5. Biotransformation and disposition characteristics of HSK7653, a novel long‐acting dipeptidyl peptidase‐4 inhibitor for the treatment of type 2 diabetes;Diabetes, Obesity and Metabolism;2024-04-22